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http://dxObjective: To determine the effect of different etiologies on the outcome and mortality after mechanical com-
posite aortic root/ascending replacement.
Methods: From February 1998 to June 2011, 448 consecutive patients (358 men, age, 52.8  12.3 years)
underwent composite mechanical aortic root replacement. Of these 448 patients, 362 (80.8%) were treated
for degenerative/atherosclerotic root/ascending aortic aneurysm (287 men, age, 53.0  12.1 years), 65
(14.5%) for emergent acute type A aortic dissection (49 men, age, 51.0  13.1 years), and 21 (4.7%) for active
infective endocarditis (20 men, age, 46.5  13.6 years); 15% (n ¼ 68) were reoperative or redo procedures.
Results: The overall hospital mortality after composite root/ascending replacement was 6.7% (n ¼ 30). It was
3.9% (n ¼ 14) after elective/urgent aneurysm replacement, 20.0% (n ¼ 13) after emergency repair for acute
type A aortic dissection, and 14.3% for active infective endocarditis (n ¼ 3). The overall 1-year mortality—
as a measure of operative success—was 5.2% (n ¼ 19) after elective/urgent degenerative/atherosclerotic
root/ascending aortic aneurysm repair, 21.5% (n¼ 14) after emergency repair for acute type A aortic dissection,
and 14.3% (n ¼ 3) after active infective endocarditis (degenerative/atherosclerotic root/ascending aortic aneu-
rysm vs acute type A aortic dissection, P¼ .03; degenerative/atherosclerotic root/ascending aortic aneurysm vs
active infective endocarditis, P ¼ .08; acute type A aortic dissection vs active infective endocarditis, P ¼ .8).
Long-term survival was 88.3% at 5 years and 72.2% at 10 years, with a linearized mortality rate after 30
days of 2.5%/patient-year. Long-term survival after surgery for acute type A aortic dissection and active infec-
tive endocarditis was 72% and 72.3% at 5 years and 64.9% and 62% at 10 years, respectively, with a linearized
mortality rate of 2.6%/patient-year for acute type A aortic dissection and 3.7% for active infective endocarditis.
Survival after composite root replacement after the first year paralleled that of an age- and gender-matched
population, regardless of the etiology. Women appeared to have less favorable longevity.
Conclusions: Composite root replacement remains a versatile choice for various pathologic features with excel-
lent longevity and freedom from reoperation and should be strongly considered if conditions for valve-sparing
repair are less than perfect. (J Thorac Cardiovasc Surg 2013;145:S41-7)Bentall and De Bono originally described their technique
for complete replacement of the aortic valve and ascending
aorta in a patient presenting with free aortic regurgitation in
1968. They used a mechanical composite graft—consisting
of a no. 13 Starr cage-ball valve attached to a crimped Tef-
lon tube—for aortic root replacement with reattachment of
the 2 main coronary arteries. Nine years later, in 1977, Kou-
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The Journal of Thoracic and Carof 25 cases using coronary buttons. The Button-Bentall be-
came one of the most significant refinements of the classic
procedure.1 In 1996, Bachet and colleagues2 were the first
to report an extensive experience of more than 200 patients,
demonstrating the superiority of the Button-Bentall and its
successful use for various etiologies.
In the early 1990s, Galla and colleagues,3 introduced the
BioBentall—a home-made composite graft manufactured
intraoperatively using a stented bioprosthesis—enabling
root replacement in patients deemed unable to take antico-
agulants. The BioBentall provided excellent long-term
survival and very low rates of thromboembolism, bleeding
complications, and reoperation.4,5
During the past decade, valve-sparing procedures have
progressively been recommended for aortic root repair, es-
pecially in younger patients. Excellent patient survival and
durability of aortic valve function in highly selected
patients with root aneurysm and normal or near-normal
aortic valve leaflets has been reported, particularly with
the reimplantation technique.6-8 The excellent clinicaldiovascular Surgery c Volume 145, Number 3S S41
Panel 1 Etz et alS4Abbreviations and Acronyms
ADA ¼ acute type A aortic dissection
AIE ¼ active infective endocarditis
CVA ¼ cerebrovascular accident
LMR ¼ linearized mortality rate
R/AsA ¼ degenerative or atherosclerotic aortic
root/ascending ectasia/aneurysm2 The Joutcome in selected patients and the lack of a need for anti-
coagulation generated increasing interest in extending the
indications for valve-sparing procedures.9,10 Increasing
reports have emerged on extensive aortic valve repair
even of bicuspid valves with a calcified raphe.11
Recently, Urbanski and colleagues5 reported the success-
ful use of composite grafts with oversized biologic valves,
particularly in patients with a small native annulus (<23
mm). They suggested the biologic valve composite graft
as an alternative for younger patients because of the ease
of reoperative replacement of the biologic valve in the
rare case of deterioration.5
The objective of the present analysiswas to provide bench-
mark data from the largest contemporary single-center expe-
rience of mechanical composite aortic root replacement.
METHODS
A review of the institutional database—of more than 1200 aortic root
procedures—disclosed 448 consecutive patients who underwent isolated
mechanical composite aortic root replacement from February 1998 to
June 2011. The indications for surgery were pathologic features affecting
the aortic valve in the presence of root/ascending aorta disease. These in-
cluded degenerative or atherosclerotic aortic root/ascending ectasia/aneu-
rysm (R/AsA), acute type A aortic dissection (ADA), and active infective
endocarditis (AIE) of a native/prosthetic aortic valve. Patients requiring
concomitant full arch repair were excluded (n ¼ 26) to allow for objective
comparison of root procedures. The institutional review board approved the
present research, and additional patient consent was not required.
Patient Demographics and Indication for Surgery
A total of 448 patients (mean age, 52.8 12.3 years; range, 18-88 years)
underwent mechanical composite aortic root replacement with a single
conduit type (size, 21-29 mm; ATS Medical, Minneapolis, Minn). Of these
patients, 362 were treated for R/AsA, 65 for ADA, and 21 for AIE. Aortic
valve dysfunction was observed in 438 of the patients (98%) and was
isolated stenosis (10%) or regurgitation (57%), or a combination of both
(31%). The clinical characteristics of all patients are listed in Table 1.
Indications for Root/Ascending Replacement
Patients with R/AsA. Most patients underwent surgery for various
aortic valve pathologic entities combined with root/ascending ectasia or
aneurysm (n ¼ 352, aneurysm in 270 and ectasia in 82). Ten patients pre-
sented with an aneurysm strictly limited to the aortic root. Two patients
underwent aortic root replacement after valve repair was unsuccessful. One
patient underwent initial valve replacement and supracommissural ascending
replacement, which resulted in distortion of the coronary ostia, warrantingournal of Thoracic and Cardiovascular Surgcomplex root revision. Finally, 42 patients (12%) had undergone previous
cardiac surgery. Of those, 26 (62%) had undergone previous aortic surgery.
Patients with ADA. A total of 65 patients underwent emergency sur-
gery for ADA. Patients with iatrogenic dissections (n ¼ 6) were excluded
owing to the confounding nature of the initial surgery. Eleven patients had
undergone previous aorta-related surgery. Two patients had aortic type A
repeat dissection at the root level (one bicuspid and one tricuspid) after pre-
vious aortic valve-sparing repair with supracommissural ascending
replacement. One had undergone previous supracommissural ascending re-
placement, required reoperative root repair (valve-remodeling, Yacoub),
experienced annulus perforation, and, eventually, received a mechanical
composite graft at his third reoperation. Three patients had previously un-
dergone isolated supracommissural ascending replacement (1, 3, and 4
years before their aortic root dissected). Five patients had undergone
previous aortic valve replacement and their aorta dissected late at 2, 6,
13, and 15 years after the previous surgery. One patient experienced annu-
lus perforation 12 years after redo aortic valve surgery.
Patients with AIE. A total of 21 patients underwent urgent surgery
for AIE of the aortic valve. A native aortic valve was present in 7 patients,
and 14 patients had prosthetic valve endocarditis. A root abscess was found
in 7 (native in 4 and prosthetic in 3). Previous endocarditis had occurred in
3 (all prosthetic), and concomitant mitral valve endocarditis was found in 2
patients. Of the 21 patients, 16 (76%) had undergone previous aortic valve
and/or ascending aortic replacement. One patient had undergone a Bentall
procedure 5 years previously to redo mechanical composite root replace-
ment for a pseudoaneurysm involving the right coronary button. The
patient also required mitral valve repair at reoperation.Surgical Technique
Cannulation. Arterial cannulation was direct—either by the ascend-
ing aorta (n ¼ 240) or the proximal arch (n ¼ 97)—in 75%. In 1 case,
primary cannulation of the carotid artery was used. The femoral artery
was used in 51 patients (11%). This was by preference of the surgeon in
24 (47%), for emergency arterial access in 13 (25.5%), because the aneu-
rysm included the aortic arch with no direct cannulation site available in 12
(23.5%), or because of a previous reoperative sternotomy in 2 (4%).
Temperature management and cerebral protection. Sur-
gery was usually performed with mild-to-moderate hypothermia (30C) with
anaverageminimal core temperature (bladder) of29.3  6C. In370patients
(83%), the distal ascending aortawas clamped during completion of the distal
anastomosis (R/AsA, 314 [87%]; ADA, 36 [55%]; and AIE, 20 [95%]).
In 30 patients (7%), antegrade selective cerebral perfusion was estab-
lished as an adjunct to hypothermic distal circulatory arrest, and open distal
anastomosis was performed (R/AsA, 13 [3.6%]; ADA, 17 [28%]; AIE,
0 [0%]), with a mean temperature of 23.9C  5C. Cannulation for ante-
grade selective cerebral perfusion was unilateral in 11 or bilateral using
a perfusion catheter in the left carotid artery in 19, as previously described.
Hypothermic circulatory arrest without antegrade selective cerebral perfu-
sion was used in 48 (11%).
Aortic root replacement. The Button-Bentall procedure as modi-
fied by Kouchoukos12 was performed in all patients, using 1 type of
mechanical composite conduit (ATS Medical). The mean prosthesis size
was 25  2 mm (range, 21-29 mm).
Partial aortic arch replacement. A total of 74 patients under-
went concomitant partial aortic arch replacement because of involvement
of the proximal aortic arch in the aneurysm or dissection (R/AsA, 46
[13%]; ADA, 26 [40%]; and AIE, 2 [9.5%]). In these cases, the concavity
of the aortic arch was resected, leaving the convexity of the transverse arch,
including the origin of the supraaortic vessels.
Concomitant procedures. Coronary artery bypass grafting was
performed in 58 patients (13%), with an average of 1.8 bypass grafts
(range, 1-5 grafts) per patient. Mitral valve surgery was undertaken in 35
patients (replacement in 14 and repair in 21). Nine patients underwentery c March 2013
TABLE 1. Clinical profile and intraoperative data
Variable All R/AsA ADA AIE
Patients (n) 448 (100) 362 (80.8) 65 (14.5) 21 (4.7)
Age (y)
Mean  SD 52.8  12 53  12 51  13 47  14
Range 18-88 18-88 20-87 28-71
Age>60 y 141 (32) 123 (34) 14 (22) 4 (19)
Male gender 356 (80) 287 (79) 49 (75) 20 (95)
Previous cardiac operations 68 (15) 42 (12) 11 (14) 17 (81)
Previous aortic operations 52 (12) 26 (7.2) 11 (14) 17 (81)
Previous MV replacement 14 (3) 12 (3) 0 (0) 2 (10)
Previous MV repair 21 (5) 18 (5) 1 (2) 2 (10)
CABG 58 (13) 46 (13) 11 (17) 1 (5)
Timing of surgery
Elective 320 (71) 313 (86) 3* (5) 4 (19)
Urgent 51 (11) 36 (10) 7 (10) 8 (38)
Emergent 77 (17) 13 (4) 55 (85) 9 (43)
Risk factors
LVEF 30% 14 (3) 13 (4) 1 (2) 0 (0)
History of hypertension 252 (56) 208 (57) 35 (54) 9 (43)
Coronary artery disease 64 (14) 54 (15) 9 (14) 1 (5)
Smoking 117 (26) 97 (27) 14 (22) 6 (29)
IDDM 24 (5) 23 (6) 1 (15) 0 (0)
COPD 11 (3) 9 (2) 1 (2) 1 (5)
Previous CVA 14 (3) 10 (3) 1 (2) 3 (14)
Intraoperative findings
Aortic stenosis 45 (10) 39 (11) 3 (5) 3 (14)
Aortic regurgitation 253 (57) 192 (53) 58 (89) 3 (14)
Both 140 (31) 130 (36) 4 (6) 6 (29)
Ascending diameter (mm) 55.1  10.9 54.8  9.7 73.9  23.4 52.0  6.6
CPB
Direct cannulation 337 (75) 305 (84) 13 (20) 19 (90)
Femoral cannulation 51 (11) 35 (10) 15 (23) 1 (5)
Axillary cannulation 60 (13) 22 (6) 37 (57) 1 (5)
Crossclamp time (min) 94.97  39.0 89.6  34.2 112.3  49.2 118.2  40.3
CPB time (min) 148.0  81.1 137.3  75 196.8  91 187.3  76
Myocardial protection
Cold antegrade blood 73 (16) 56 (15) 11 (17) 6 (29)
Crystalloid cardioplegiay 375 (84) 306 (85) 54 (83) 15 (71)
Data presented as mean standard deviation or n (%). R/AsA, Degenerative or atherosclerotic aortic root/ascending ectasia/aneurysm; ADA, acute type A aortic dissection; AIE,
active infective endocarditis; MV, mitral valve; CABG, coronary artery bypass grafting; LVEF, left ventricular ejection fraction; IDDM, insulin-dependent diabetes mellitus;
COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; CPB, cardiopulmonary bypass; SD, standard deviation. *Chronic. yBretschneider HTK, K€ohler
Chemie, Alsbach-H€ahnlein, Germany.
Etz et al Panel 1septal myectomy for hypertrophic left ventricular outflow tract obstruction.
Minor concomitant procedures included cryoablation or radiofrequency
ablation in 11 and left atrial appendage ligation in 4.
Follow-up
The patients were followed up by the referring cardiologist and con-
tacted periodically by our research personnel either through outpatient visit
and telephone interviews or by questionnaire. The follow-up data were
100% complete, with a mean duration of 5.8  3.7 years (range, 0.1-
13.1 years; median, 6.3 years) and was closed July 18, 2011.Statistical Analysis
Data were imported to SPSS, version 17.0 (SPSS, Chicago, Ill) for
description and analysis. Differences between groups were analyzed using
the Student t test and chi-square test, as appropriate. Kaplan-Meier curvesThe Journal of Thoracic and Carwere calculated and tested by log-rank analysis to describe the differences
in long-term survival among the groups. All tests were performed as
2-sided at a significance level of 5%.
Factors influencing survival were initially explored by separate univar-
iate analyses, each considering factors related to in-hospital or long-term
death. After the univariate analysis, the factors that showed a significant
influence on survival were analyzed by multivariate analyses using either
Cox regression analysis for time-dependent data or logistic regression anal-
ysis for binary data. Risk factor analyses were performed separately for
each and for all etiologies combined.RESULTS
Hospital Mortality
The overall hospital mortality (defined as death before
discharge or within 30 days after surgery), including alldiovascular Surgery c Volume 145, Number 3S S43
Panel 1 Etz et alemergencies, regardless of etiology, was 6.7% (n¼ 30). For
elective or urgent repair, it was 3.9% (14/362), without sig-
nificant differences between the primary and reoperative
patients (3.4% [11/320] vs 7.1% [3/42], P ¼ .223). The
in-hospital mortality for R/AsA was significantly lower
than for emergency surgery for ADA or urgent operation
for AIE (ADA, 20.0%, n ¼ 13/65, P ¼ .001; and AIE,
14.3%, n ¼ 3/21, P ¼ .003). For ADA and AIE, the in-
hospital mortality was comparable (P ¼ .750). Adjustment
for age and gender when comparing R/AsAwith ADA and
AIE did not alter the statistical significance.Postoperative Course and Complications
The overall prevalence of postoperative complications
showed no significant difference between the etiologic sub-
groups (P¼ .536; Table 2), except for sepsis (R/AsA, n¼ 4
[1.1%]; ADA, n¼ 5 [7.7%]; AIE, n¼ 1 [4.8%]; P¼ .003)
and respiratory failure (R/AsA, n ¼ 19 [5.2%]; ADA,
n ¼ 10 [15.4%]; AIE, n ¼ 2 [9.5%]; P ¼ .012).Long-Term Survival, Linearized Mortality Rates,
and Comparison With an Age- and Gender-Matched
Normal Population
The overall survival after 14 years for R/AsA was 63%
and 70.3% for all primary elective and urgent patients
(P ¼ .212). Detailed 1-year mortality and 5- and 10-year
survival data are listed in Table 3. The patients after surgery
for R/AsA had a linearized mortality rate (LMR, after 30
days) of 2.5%/patient-year. For patients with ADA, the
LMR was 2.6%, and for AIE, it was 3.7%/patient-year. A
comparison of the survival of the entire cohort with anTABLE 2. Postoperative complications and cause of death







44 (9.8) 37 (10.2) 3 (4.6) 4 (19.0) .134
Bleeding 68 (15.2) 53 (14.6) 14 (21) 1 (4.8) .118
Sepsis 10 (2.2) 4 (1.1) 5 (7.7) 1 (4.8) .003
CPR 12 (2.7) 10 (2.8) 2 (3.1) 0 (0) .739
Stroke 24 (5.4) 19 (5.2) 5 (7.7) 0 (0) .437
New dialysis 1 (0.2) 1 (0.3) 0 (0) 0 (0) .911
Respiratory failure 31 (6.9) 19 (5.2) 10 (15.4) 2 (9.5) .012*
Cause of death
Multiorgan failure 6 (1.3) 4 (1.1) 1 (1.5) 1 (4.8) .414
Acute heart failure 15 (3.3) 11 (3.0) 2 (3.1) 2 (9.5) .334
Acute respiratory
failure
6 (1.3) 4 (1.1) 1 (1.5) 1 (4.8) .426
Othery 67 (15.0) 48 (13.3) 17 (26.2) 2 (9.5) .023*
Data presented as n (%). R/AsA, Degenerative or atherosclerotic aortic root/ascend-
ing ectasia/aneurysm; ADA, acute type A aortic dissection; AIE, active infective
endocarditis; CPR, cardiopulmonary resuscitation. *Significant difference between
R/AsA and ADA only. yMalignancy, noncardiac surgery, and unknown.
S44 The Journal of Thoracic and Cardiovascular Surgage- and gender-matched, normal East German population
is shown in Figures 1 and 2. Despite less favorable short-
term outcomes for patients with ADA and AIE compared
with those with R/AsA, the long-term outcome was equiv-
alent among the groups (P ¼ .733; Figure 3).
Long-Term Adverse Events and Freedom From
Reoperation
The complications considered during long-term follow-
up were aorta-related reoperation, stroke, and severe bleed-
ing. Stroke accounted for 4.5% of adverse events during
long-term follow-up (n ¼ 20; R/AsA, n ¼ 16 [4.4%];
ADA, n ¼ 4 [6.2%]; AIE, n ¼ 0) occurring 1 to 12 years
postoperatively (median, 6.4 years). Severe bleeding com-
plications occurred in 5 patients (2%) (R/AsA, n ¼ 4
[1.1%]; ADA, n ¼ 1 [1.5%]; AIE, n ¼ 0) 3 to 9 years
postoperatively (median, 7.2 years; with gastrointestinal
bleeding in 3 and intramuscular bleeding in 1). Only 1
patient experienced spontaneous cerebrovascular hemor-
rhage, with no previous reported trauma. Freedom from
aorta-related reoperation during the entire follow-up pe-
riod was 98% for the patients with R/AsA (n ¼ 6), 92%
for those with ADA (n ¼ 5), and 86% for those with
AIE (n ¼ 3).
Elective Patients With Pure Regurgitation for
Comparison
We compiled an artificially assembled cohort that was
potentially eligible for valve-sparing procedures and for
comparison purposes only consisting of patients who had
undergone elective and urgent primary surgery for R/AsA
and urgent surgery for ADA and who had isolated aortic re-
gurgitation (mean age, 53.5  12.2 years). The overall hos-
pital mortality was 1.1% (1/89) for this group. The overall
prevalence of postoperative complications was not signifi-
cantly different from that for the entire cohort. The overall
1-year mortality in this cohort was 5.6% (5/89) with 5- and
10-year survival of 92% and 78%, respectively. The LMR
was 2.3%/patient-year. Freedom from aorta-related reoper-
ation was 97.8% at 10 years. Freedom from bleeding or
thromboembolic events was 98.9% and 95.6% at 5 and
10 years, respectively.
Risk Factors
Multivariate analysis of all deaths occurring after me-
chanical composite aortic root replacement identified age,
previous cerebrovascular accidents (CVAs), and emergency
surgery as highly significant risk factors (Table 1 and
Figure 1). Female gender and a prolonged crossclamp
time during surgery also had a significant adverse effect
on survival. The adverse effect of aortic reoperation on sur-
vival was of borderline significance (P ¼ .072). In patients
undergoing surgery for ADA, a reduced left ventricular
ejection fraction was associated with an eightfold increasedery c March 2013
TABLE 3. Mortality and survival
Variable R/AsA ADA AIE
P value
R/AsA vs ADA R/AsA vs AIE ADA vs AIE
Mortality
In-hospital 3.9 (14/362) 20.0 (13/65) 14.3 (3/21) .001 .003 .750
1 y 5.2 (19/362) 21.5 (14/65) 14.3% (3/21) .033 .079 .779
Survival (%)
5 y 88.3 72 72.3 .001 .086 .795
10 y 72.2 64.9 62 .035 .276 .886
5 y (>30 d) 92.2 84.5 79.9 .059 .094 .854
10 y (>30 d) 75.3 76.2 68.5 .287 .293 .800
Data presented as% (n/n). R/AsA,Degenerative or atherosclerotic aortic root/ascending ectasia/aneurysm; ADA, acute type A aortic dissection; AIE, active infective endocarditis.
Etz et al Panel 1risk of death (hazard ratio, 8.1; P ¼ .053). Among patients
with R/AsA, concomitant mitral valve replacement and
insulin-dependent diabetes mellitus doubled the risk (haz-
ard ratio, 2.2; P ¼ .061 and P ¼ .044, respectively).
DISCUSSION
Cohort Analysis
The overall mean age and gender distribution of our
cohort was typical for patients requiring mechanical com-
posite aortic root replacement.13,14 A history of smoking
and chronic hypertension was equally frequent among all
etiologies. Cohorts undergoing composite R/AsA repairFIGURE 1. Left, Kaplan-Meier long-term survival curve for patients after me
gender-matched East German population. Right, Multivariate risk factors for lon
age, gender, history of hypertension, insulin-dependent diabetes mellitus, chroni
artery disease, number of previous procedures, urgency of procedure, concomit
mitral valve replacement or repair, axillary artery cannulation, and selective ce
The Journal of Thoracic and Carusually were older than those undergoing valve-sparing pro-
cedures, even in reference centers for valve sparing, and
included patients with calcified and stenotic disease.7
Patients requiring total arch replacement for distal ascend-
ing or transverse arch disease represent a distinct group of
patients, with often diminished longevity because of the
extensive generalized vascular disease determining survival
and were, therefore, excluded from the present analysis.7,15
Patients requiring aortic root replacement combined
with mitral valve surgery represent the other distinct
subgroup with a complex operation associated with high
morbidity.16chanical composite aortic root replacement and comparison with age- and
g-term survival in Forest plot. Risk factors considered for analysis included
c obstructive pulmonary disease, left ventricular ejection fraction, coronary
ant procedures, concomitant coronary artery bypass grafting, concomitant
rebral perfusion. CVA, Cerebrovascular accident.
diovascular Surgery c Volume 145, Number 3S S45
FIGURE 2. Long-term survival after 1 year. Pts., Patients.
Panel 1 Etz et alComparison of Intraoperative Data
The rate of diabetes, chronic obstructive pulmonary dis-
ease, and CVAs was unexpectedly low, particularly among
patients with aneurysm, even though more than one third
were older than 60 years. Direct cannulation was the stan-
dard arterial access in 80% of elective patients undergo-
ing R/AsA repair, but only 20% of patients with ADA
were cannulated directly. The recent trend toward moreFIGURE 3. Kaplan-Meier survival curve after mechanical composite aor-
tic root replacement for all etiologies (hospital mortality excluded). ADA,
Acute type A aortic dissection; AIE, active infective endocarditis; R/AsA,
degenerative or atherosclerotic aortic root/ascending ectasia/aneurysm.
S46 The Journal of Thoracic and Cardiovascular Surgfrequent axillary cannulation and more restrictive use of
the femoral arteries for arterial access reflects the belief
that axillary cannulation significantly improves survival
and neurologic outcomes after atherosclerotic aneurysm
repair of the aortic root and ascending aorta.17
Differences and Similarities Between Our Cohort
and Others
In our cohort, fewer than 5% of patients with aneurysm
underwent emergent surgery, reflecting in part the success
of our surveillance program in timing the surgery appropri-
ately. The overall hospital mortality was 6.7%, regardless of
the etiology, and compares favorablywith that from contem-
porary series of composite root replacement. Hospital mor-
tality for elective composite R/AsA repair was as low as that
for elective aortic valve replacement and slightly greater
than the reported numbers for contemporary valve-sparing
series, likely reflecting the greater percentage of patients
with calcified stenosis and more generalized vascular dis-
ease and more advanced mean age. Among patients under-
going emergency surgery for ADA, the hospital mortality
was comparable to that of other series with likely less severe
concomitant pathologic features and lower mean age. The
hospital mortality among patients undergoing composite
root repair for AIE was rather low; however, the sample
size was small, and the patients were relatively young.
The overall 1-year survival, likely representing the true
operative mortality for these extensive surgical procedures,
was 92% and significantly different for patients undergoing
urgent or emergent surgery for ADA or AIE than for those
undergoing primary elective R/AsA (P ¼ .009 and
P ¼ .001, respectively). Thereafter, however, the LMR
aligned, and survival beyond 30 days was not significantly
different statistically after 5 (P ¼ .06-.9) or 10 (P ¼ .3-.8)
years (Table 3).
Risk Factor Interpretation
Patient age and crossclamp time clearly—and not sur-
prisingly—were risk factors for overall, early, and long-
term mortality, regardless of the etiology. Emergency
surgery tripled overall mortality, increased the risk of early
death almost sixfold, and influenced longevity, even after
hospital discharge or after 30 days, regardless of the etiol-
ogy. Female gender was a risk factor for overall, early,
and long-term mortality, with a hazard ratio of 1.6 and bor-
derline significance (P ¼ .051 and P ¼ .074; Figure 1). A
previous CVA was associated with a threefold increased
risk of early mortality and quadrupled the overall mortality,
regardless of etiology.
Among the patients with ADA, a reduced left ventricular
ejection fraction was associated with an eightfold increase
in mortality, likely reflecting the presence of acute ischemia
due to coronary compromise. Women with ADA still had
a fourfold increased risk of death after discharge andery c March 2013
Etz et al Panel 1beyond 30 days. In patients with AIE, the overall mortality
was increased 10-fold, most likely reflecting the deleterious
effects of septic emboli. A left ventricular ejection fraction
less than 30% was associated with a six- to eightfold
increase in early mortality among those with ADA and
R/AsA but did not reach statistical significance (P ¼ .073).
Freedom From Bleeding and Thromboembolic
Events
The major disadvantage of mechanical composite root
replacement is the burden of lifelong anticoagulation. The
incidence of severe hemorrhage and thromboembolic
events was low—a finding in line with previous reports
from similar cohorts.
Implications Regarding Valve Sparing
We compared an artificially assembled subset of patients
potentially eligible for valve-sparing procedures (patients
with elective/urgent primary R/AsA and urgent ADA and
pure aortic regurgitation). We found their survival in the
present series was equivalent to data reported on valve-
sparing procedures up to 10 years postoperatively (for
remodeling and reimplantation, 83%  5% at 8 years
and 82.9%  3.7% at 12 years).6,7 A less favorable
overall outcome, however, would be expected for patients
undergoing primary composite Bentall operations than for
patients undergoing a David procedure (reimplantation),
who have excellent 10-year survival of 92%  3%.18
This survival advantage might be related, in part, to the
older mean age of patients undergoing composite root
replacement (mean age in reimplantation cohort, 45  15
years18) and the inclusion of more severe pathologic find-
ings among the Bentall patients. Freedom from reoperation
in the present series was also better among the composite
patients than has been reported after valve-sparing proce-
dures (98% vs 95% at 10 years). Recurrent aortic regurgi-
tation and limited patient eligibility are the major
disadvantages of valve-sparing procedures, although the
reimplantation technique offers excellent, and potentially
superior, results in highly selected patients with mild to
moderate regurgitation and normal leaflets.
CONCLUSIONS
The patients who underwent emergent surgery for ADA
and AIE had less favorable short-term outcomes than the
patients with R/AsA who underwent elective surgery. Sur-
vival after composite root replacement beyond the first
year paralleled that of an age- and gender-matched popula-
tion and was similar for the 3 compared etiologies. Female
gender was an independent risk factor for long-termmortal-
ity, as described previously for Bentall procedures, although
we do not yet have an explanation. Also, previous CVAwas
a highly significant independent risk factor for death after
mechanical aortic root replacement, possibly connected toThe Journal of Thoracic and Carthe enhanced risk entailed in the mandatory use of warfarin
and the threat of recurrent fatal CVA.
Composite root replacement remains a choicewith excel-
lent durability and freedom from reoperation, particularly
for patients with severe and acute etiologies and/or calcified
valvular or root disease. Composite root replacement
remains a good option, offering excellent longevity, very
low reoperation rates, and, likely, fewer bleeding and
thromboembolic complications than expected. It deserves
serious consideration if conditions for repair are less than
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